Fixing the leak: targeting the vascular endothelium in sepsis

Critical Care

Volumn 16, Issue 6, 2012, Pages

  Spicer, Aaron ^a   Calfee, Carolyn S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

MOLECULARLY TARGETED THERAPY; NONHUMAN; NOTE; PRIORITY JOURNAL; SEPSIS; SKINFOLD; VASCULAR ENDOTHELIUM; ANIMAL; DISEASE MODEL; GENETIC VARIABILITY; GENETICS; HUMAN; MALE; MICROCIRCULATION; PHYSIOLOGY;

ANGIOPOIETIN-1; ANIMALS; DISEASE MODELS, ANIMAL; GENETIC VARIATION; HUMANS; MALE; MICROCIRCULATION; SEPSIS;

EID: 84869499934     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11829     Document Type: Note

References (20)

1. Alfieri A, Watson JJ, Kammerer RA, Tasab M, Progias P, Reeves K, Brown NJ, Brookes ZL. Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis. Crit Care 2012, 16:R182. 10.1186/cc11666, 23036162.
2. Hirschberg R, Wang S, Mitu GM. Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008, 331:485-493. 10.1007/s00441-007-0526-z, 17999087.
3. Neagoe PE, Brkovic A, Hajjar F, Sirois MG. Expression and release of angiopoietin-1 from human neutrophils: intracellular mechanisms. Growth Factors 2009, 27:335-344. 10.3109/08977190903155043, 19919521.
4. Dumas E, Martel C, Neagoe PE, Bonnefoy A, Sirois MG. Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor. Biochim Biophys Acta 2012, 1823:358-367. 10.1016/j.bbamcr.2011.12.002, 22198097.
5. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 2009, 29:2011-2022. 10.1128/MCB.01472-08, 2663314, 19223473.
6. David S, Mukherjee A, Ghosh CC, Yano M, Khankin EV, Wenger JB, Karumanchi SA, Shapiro NI, Parikh SM. Angiopoietin-2 may contribute to multiorgan dysfunction and death in sepsis. Crit Care Med 2012, 40:3034-3041. 10.1097/CCM.0b013e31825fdc31, 22890252.
7. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, Karumanchi SA, Sukhatme VP. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006, 3:e46. 10.1371/journal.pmed.0030046, 1334221, 16417407.
8. Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DS, Stephens DP, Anstey NM. Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 2010, 14:R89. 10.1186/cc9020, 2911723, 20482750.
9. Kumpers P, Lukasz A, David S, Horn R, Hafer C, Faulhaber-Walter R, Fliser D, Haller H, Kielstein JT. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008, 12:R147. 10.1186/cc7130, 2646310, 19025590.
10. Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA, NHLBI ARDS N. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med 2012, 40:1731-1737. 10.1097/CCM.0b013e3182451c87, 22610178.
11. Ricciuto DR, dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, Laff erty EI, Cook DJ, Fox-Robichaud A, Kahnamoui K, Kain KC, Liaw PC, Liles WC. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med 2011, 39:702-710. 10.1097/CCM.0b013e318206d285, 21242795.
12. Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, Lee SH, Yasunaga K, Kim KT, Kim I, Choi HH, Kim W, Kim SH, Park SK, Lee GM, Koh GY. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 2004, 101:5547-5552. 10.1073/pnas.0307574101, 397420, 15060279.
13. David S, Park JK, Meurs M, Zijlstra JG, Koenecke C, Schrimpf C, Shushakova N, Gueler F, Haller H, Kumpers P. Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. Cytokine 2011, 55:251-259. 10.1016/j.cyto.2011.04.005, 21531574.
14. Kumpers P, Gueler F, David S, Slyke PV, Dumont DJ, Park JK, Bockmeyer CL, Parikh SM, Pavenstadt H, Haller H, Shushakova N. The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Crit Care 2011, 15:R261. 10.1186/cc10523, 3334812, 22040774.
15. Hwang JA, Lee EH, Lee SD, Park JB, Jeon BH, Cho CH. COMP-Ang1 ameliorates leukocyte adhesion and reinforces endothelial tight junctions during endotoxemia. Biochem Biophys Res Commun 2009, 381:592-596. 10.1016/j.bbrc.2009.02.096, 19245790.
16. Kim DH, Jung YJ, Lee AS, Lee S, Kang KP, Lee TH, Lee SY, Jang KY, Moon WS, Choi KS, Yoon KH, Sung MJ, Park SK, Kim W. COMP-angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney Int 2009, 76:1180-1191. 10.1038/ki.2009.387, 19812542.
17. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005, 111:97-105. 10.1161/01.CIR.0000151287.08202.8E, 15611372.
18. Huang YQ, Sauthoff H, Herscovici P, Pipiya T, Cheng J, Heitner S, Szentirmai O, Carter B, Hay JG. Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med 2008, 36:262-267. 10.1097/01.CCM.0000297955.02633.A4, 18007265.
19. McCarter SD, Mei SH, Lai PF, Zhang QW, Parker CH, Suen RS, Hood RD, Zhao YD, Deng Y, Han RN, Dumont DJ, Stewart DJ. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007, 175:1014-1026. 10.1164/rccm.200609-1370OC, 17322110.
20. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007, 4:e269. 10.1371/journal.pmed.0040269, 1961632, 17803352.